Publications by authors named "Brian D VanScoy"

Claim this Profile
P
Pharmacokinetic-Pharmacodynamic Target Attainment Analyses Evaluating Omadacycline Dosing Regimens for the Treatment of Patients with Community-Acquired Bacterial Pneumonia Arising from Streptococcus pneumoniae and Haemophilus influenzae.
Sujata M Bhavnani, Jeffrey P Hammel, Elizabeth A Lakota, Michael Trang, Justin C Bader, Brian D VanScoy

Antimicrob Agents Chemother· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gepotidacin Pharmacokinetics-Pharmacodynamics against Escherichia coli in the One-Compartment and Hollow-Fiber Infection Model Systems.
Brian D VanScoy, Elizabeth A Lakota, Haley Conde, Steven Fikes, Sujata M Bhavnani

Antimicrob Agents Chemother· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic-Pharmacodynamic Target Attainment Analyses To Support Dose Selection for ME1100, an Arbekacin Inhalation Solution.
Sujata M Bhavnani, Jeffrey P Hammel, Elizabeth A Lakota, M Courtney Safir, Brian D VanScoy

Antimicrob Agents Chemother· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between Gepotidacin Exposure and Prevention of On-Therapy Resistance Amplification in a Neisseria gonorrhoeae Hollow-Fiber Infection Model.
Brian D VanScoy, Nicole E Scangarella-Oman, Steven Fikes, Sharon Min, Jianzhong Huang

Antimicrob Agents Chemother· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic-Pharmacodynamic Characterization of Omadacycline against Haemophilus influenzae Using a One-Compartment Infection Model.
Brian D VanScoy, Elizabeth A Lakota, Haley Conde, Jennifer McCauley, Lawrence Friedrich

Antimicrob Agents Chemother· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apotransferrin in Combination with Ciprofloxacin Slows Bacterial Replication, Prevents Resistance Amplification, and Increases Antimicrobial Regimen Effect.
Paul G Ambrose, Brian D VanScoy, Brian M Luna, Jun Yan, Amber Ulhaq

Antimicrob Agents Chemother· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Ceftolozane-Tazobactam in Combination with Meropenem against Pseudomonas aeruginosa Sequence Type 175 in a Hollow-Fiber Infection Model.
M Montero, Brian D VanScoy, Carla López-Causapé, Haley Conde, Jonathan Adams

Antimicrob Agents Chemother· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Norepinephrine in Combination with Antibiotic Therapy Increases both the Bacterial Replication Rate and Bactericidal Activity.
Paul G Ambrose, Brian D VanScoy, John Adams, Steven Fikes, Justin C Bader

Antimicrob Agents Chemother· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics-Pharmacodynamics of CB-618 in Combination with Cefepime, Ceftazidime, Ceftolozane, or Meropenem: the Pharmacological Basis for a Stand-Alone β-Lactamase Inhibitor.
Paul G Ambrose, Brian D VanScoy, Michael Trang, Jennifer McCauley-Miller, Haley Conde

Antimicrob Agents Chemother· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Cefepime in an Infection Model.
Brian D VanScoy, David Tenero, Simon Turner, David M Livermore, Jennifer McCauley

Antimicrob Agents Chemother· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics-Pharmacodynamics of a Novel β-Lactamase Inhibitor, CB-618, in Combination with Meropenem in an In Vitro Infection Model.
Brian D VanScoy, Michael Trang, Jennifer McCauley, Haley Conde, Sujata M Bhavnani

Antimicrob Agents Chemother· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Piperacillin in an In Vitro Infection Model.
Anthony M Nicasio, Brian D VanScoy, Rodrigo E Mendes, Mariana Castanheira, Catharine C Bulik

Antimicrob Agents Chemother· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploration of the Pharmacokinetic-Pharmacodynamic Relationships for Fosfomycin Efficacy Using an In Vitro Infection Model.
Brian D VanScoy, Jennifer McCauley, Evelyn J Ellis-Grosse, Olanrewaju O Okusanya, Sujata M Bhavnani

Antimicrob Agents Chemother· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between ceftolozane-tazobactam exposure and selection for Pseudomonas aeruginosa resistance in a hollow-fiber infection model.
Brian D VanScoy, Rodrigo E Mendes, Mariana Castanheira, Jennifer McCauley, Sujata M Bhavnani

Antimicrob Agents Chemother· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of spores on the comparative efficacies of five antibiotics for treatment of Bacillus anthracis in an in vitro hollow fiber pharmacodynamic model.
Arnold Louie, Brian D VanScoy, David L Brown, Robert W Kulawy, Henry S Heine

Antimicrob Agents Chemother· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential effects of linezolid and ciprofloxacin on toxin production by Bacillus anthracis in an in vitro pharmacodynamic system.
Arnold Louie, Brian D Vanscoy, Henry S Heine, Weiguo Liu, Terry Abshire

Antimicrob Agents Chemother· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose range evaluation of Mycograb C28Y variant, a human recombinant antibody fragment to heat shock protein 90, in combination with amphotericin B-desoxycholate for treatment of murine systemic candidiasis.
Arnold Louie, Daniel S Stein, Julia Z Zack, Weiguo Liu, Haley Conde, Brian D Vanscoy

Antimicrob Agents Chemother· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis